Viewing Study NCT05808335


Ignite Creation Date: 2025-12-24 @ 10:30 PM
Ignite Modification Date: 2025-12-25 @ 8:03 PM
Study NCT ID: NCT05808335
Status: UNKNOWN
Last Update Posted: 2023-06-15
First Post: 2023-03-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)
Sponsor: ImmuneMed, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module